Horia Bumbea

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C. Rawstron, Meral Beksaç, Ludmila Bezdîčková et al. · Haematologica · 2008 · 514 citations · Full text

Medicine, Hematology, Pathology +17

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 347 citations

Pharmacy, Hematology, Pharmacotherapy +5

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report

Lucy Cook, Shigeo Fuji, Olivier Hermine et al. · Journal of Clinical Oncology · 2019 · 257 citations · Full text

Medicine, Molecular Medicine, Oncology +14

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry

Vanessa E. Kennedy, Cecelia Perkins, Andreas Reiter et al. · Blood Advances · 2022 · 40 citations · Full text

Life Sciences, Genetics, Oncology +16